FREWITT SA located in Granges-Paccot, Switzerland, and Acino headquartered in Zurich, Switzerland, are pleased to announce a successful collaboration in micronization, notably with Acino’s acquisition of three OscilloWitt-6 (OW-6) fine grinding systems, which are part of the FREWITT LINE of mills.
“Acino recognized the most efficient manner to size reduce high-value added, sensitive powder to a tight D90 while maintaining a good throughput, as well as protecting the product characteristics was to use Frewitt’s OscilloWitt process”, explained FREWITT’s Commercial Director, Roy Housh.
“At Acino, we strive to continuously improve our processes, while developing and manufacturing high-quality pharmaceuticals for the benefit of our patients worldwide. The Frewitt machinery enables us to guarantee the high-quality standards we have implemented for our oral solid dosage activities in Switzerland, and we are pleased to continue our cooperation”, stated, Site Head Switzerland, Dr. André Ridder.
Learn more about FREWITT SA
Thanks to its experience in the grinding and milling of powders, Frewitt has established itself over time as a leader in this field by constantly anticipating the needs of its markets, including Pharmaceutical, Fine chemical, Foods, and Defense and developing tools for processes accordingly. Its worldwide presence (Global HQ in Switzerland, with branch offices in the USA, Germany, China, and India, enable it to be as close as possible to its customers.
Learn more about Acino
Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on selected markets in the Middle East, Africa, the CIS Region, Russia and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing.